{
  "catalogId": "b7dfcb39-bcc7-4da1-bb1c-5b7f0243aeaa",
  "name": "ORSERDU 345 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "176 11 37712 99",
  "treatmentDescriptions": "Orserdu is indicated for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ELACESTRANT AS DIHYDROCHLORIDE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L02BA04",
      "name": "ELACESTRANT"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ORSERDU 345 MG 30 TAB",
      "manufacturer": {
        "name": "סטמליין ישראל",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "9483",
        "yarpa": "63137",
        "barcode": "7290019908074"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 37503.96829,
        "retailMargin": 10.0,
        "maxRetailPrice": 41254.36512,
        "maxPriceWithVAT": 48680.14867
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.006901"
  }
}